XPH

SPDR S&P Pharmaceuticals ETF
*Unless otherwise stated, data provided by FactSet.

XPH Fund Description

XPH tracks an equal-weighted index of US pharmaceutical companies.

XPH Factset Analytics Insight

XPH offers equal-weighted exposure to a narrow selection of US pharmaceutical companies, stretching across all market caps. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. The fund also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. Overall, XPH is a solid way to capture a less concentrated version of the pharma market. The index is rebalanced quarterly.

PERFORMANCE [as of 05/17/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
XPH -7.23% -3.42% -8.76% -14.33% 3.09% 1.01% 6.43%
XPH (NAV) -12.49% -3.42% -8.69% -14.21% 3.12% 1.02% 6.44%
S&P Pharmaceuticals Select Industry -- -3.49% -8.81% -14.27% 3.21% 1.13% 6.59%
MSCI USA IMI / Pharmaceuticals -IND -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

XPH Summary Data

SPDR
06/19/06
Open-Ended Fund
0.35%
$188.79M
$3.34M
0.07%

XPH Portfolio Data

$71.94B
-31.92
3.64
1.34%
06/21/22
48

XPH Index Data

S&P Pharmaceuticals Select Industry
Equal
Market Cap
MSCI USA IMI / Pharmaceuticals -IND

XPH Portfolio Management

0.35%
-0.15%
0.06%
-0.42%

XPH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

XPH Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

XPH Factset Analytics Block Liquidity

As of 05/19/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XPH. XPH is rated a 5 out of 5.

XPH Tradability

76,222
$3.34M
52,253
$2.20M
0.07%
$0.03
0.00%
0.13% / -0.85%
None
89.00%
50,000
1.05
0.01%
0.13%
291
$41.95
5

XPH Sector/Industry Breakdown


XPH
Segment Benchmark
95.58%
--
4.31%
--
0.11%
--

XPH Top 10 Holdings[View All]

Catalent Inc 4.96%
Pfizer Inc. 4.89%
51.88%

XPH Countries


XPH
Segment Benchmark
100.00%
--

XPH Regions


XPH
Segment Benchmark
100.00%
--

XPH Economic Development


XPH
Segment Benchmark
100.00%
--

XPH Performance Statistics

--
--
--
--
--
MSCI USA IMI / Pharmaceuticals -IND

XPH Benchmark Comparison Holdings

48
--
--
--

XPH Benchmark Comparison Summary


XPH
Segment Benchmark
48
--
$71.94B
--
-31.92
--
3.64
--
1.09%
--
Medium
--

XPH Benchmark Comparison Market Cap Size


XPH
Segment Benchmark
41.22%
--
30.05%
--
23.14%
--
5.58%
--